The Biden administration has purchased 600,000 treatment courses of a new COVID-19 monoclonal antibody drug that data shows works against the omicron variant of the CCP (Chinese Communist Party) virus.
Known as bebtelovimab, the drug is manufactured by Eli Lilly and Company, an American pharmaceutical company headquartered in Indianapolis, Indiana.
